{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:29:58Z","timestamp":1791041398640,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010893.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000}}],"reference-count":116,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010893.pub4","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T14:09:22Z","timestamp":1648562962000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Interventions for reducing inflammation in familial Mediterranean fever"],"prefix":"10.1002","volume":"2022","author":[{"given":"Xi","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; West China Hospital, Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; West China Hospital, Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; West China Hospital, Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; West China Hospital, Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD010893.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1078\/094471103322004767","article-title":"Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard \u2013 a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with familial Mediterranean fever","volume":"10","author":"Amaryan","year":"2003","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.niox.2003.08.005","article-title":"Plasma nitric oxide level in familial Mediterranean fever and its modulations by Immuno-Guard","volume":"9","author":"Panossian","year":"2003","journal-title":"Nitric Oxide: Biology and Chemistry"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/art.39995","article-title":"Anakinra for colchicine-resistant familial Mediterranean fever: a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Ben-Zvi","year":"2017","journal-title":"Arthritis & Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD010893.pub4-BIB0004|cit4","first-page":"271","article-title":"Colchicine failure in familial Mediterranean fever and potential alternatives: embarking on the anakinra trial","volume":"16","author":"Ben-Zvi","year":"2014","journal-title":"Israel Medical Association Journal"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010893.pub4-BIB0005|cit5","first-page":"3205","article-title":"Efficacy and safety of canakinumab in patients with periodic fever syndromes (colchicine-resistant FMF, HIDS\/MKD and TRAPS): results from a phase 3, pivotal, umbrella trial","volume":"15","author":"De Benedetti","year":"2017","journal-title":"Pediatric Rheumatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010893.pub4-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/annrheumdis-2018-eular.5246","article-title":"Long-term efficacy and safety of canakinumab in patients with colchicine resistant FMF (CRFMF), TRAPS and HIDS\/MKD: results from the pivotal phase 3 cluster trial","volume":"77","author":"De Benedetti","year":"2018","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"20","key":"10.1002\/14651858.CD010893.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"S10","key":"10.1002\/14651858.CD010893.pub4-BIB0008|cit8","first-page":"1894","article-title":"Genetic phenotypes impacting efficacy and safety of canakinumab in patients with colchicine-resistant FMF, TRAPS and HIDS\/MKD: results from cluster study","volume":"69","author":"De Benedetti","year":"2017","journal-title":"Arthritis & Rheumatology"},{"issue":"S10","key":"10.1002\/14651858.CD010893.pub4-BIB0009|cit9","first-page":"398","article-title":"Improvement of disease activity in patients with colchicine-resistant FMF, HIDS\/MKD and TRAPS assessed by AutoInflammatory Disease Activity Index (AIDAI): results from a randomized phase III trial","volume":"69","author":"Kone-Paut","year":"2017","journal-title":"Arthritis & Rheumatology"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0010|cit10","first-page":"2379","article-title":"Effect of canakinumab on health-related quality of life in patients with periodic fever syndromes","volume":"15","author":"Lachmann","year":"2017","journal-title":"Pediatric Rheumatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010893.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/annrheumdis-2019-eular.1176","article-title":"Canakinumab improves patient-reported outcomes in patients with recurrent fever syndromes: results from a phase 3 trial (CLUSTER)","volume":"78","author":"Lachmann","year":"2019","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"10","key":"10.1002\/14651858.CD010893.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/annrheumdis-2020-217419","article-title":"Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial","volume":"79","author":"Ozen","year":"2020","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"18","key":"10.1002\/14651858.CD010893.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJM197410312911804","article-title":"Colchicine therapy for familial Mediterranean fever. A double blind trial","volume":"291","author":"Dinarello","year":"1974","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0014|cit14","first-page":"186","article-title":"Colchicine therapy of familial Mediterranean fever","volume":"87","author":"Wolff","year":"1974","journal-title":"Transactions of the Association of American Physicians"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-81-6-792","article-title":"Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study","volume":"81","author":"Goldstein","year":"1974","journal-title":"Annals of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD010893.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-157-8-201210160-00003","article-title":"Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial","volume":"157","author":"Hashkes","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010893.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"O38","DOI":"10.1186\/1546-0096-9-S1-O38","article-title":"Rilonacept (interleukin-1 trap) for treatment of colchicine resistant familial Mediterranean fever: a randomized, multicenter double-blinded, alternating treatment phase II trial","volume":"9","author":"Hashkes","year":"2011","journal-title":"Pediatric Rheumatology"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/854842","article-title":"The effect of rilonacept versus placebo on health-related quality of life in patients with poorly controlled familial Mediterranean fever","volume":"854842","author":"Hashkes","year":"2014","journal-title":"BioMed Research International"},{"issue":"7","key":"10.1002\/14651858.CD010893.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/000992280404300703","article-title":"Once-daily use of colchicine in children with familial Mediterranean fever","volume":"43","author":"Kosan","year":"2004","journal-title":"Clinical Pediatrics"},{"issue":"85","key":"10.1002\/14651858.CD010893.pub4-BIB0020|cit20","first-page":"1","article-title":"Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever \u2013 a randomized controlled non-inferiority trial","volume":"18","author":"Polat","year":"2016","journal-title":"Arthritis Research & Therapy"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-86-2-162","article-title":"Efficacy of intermittent colchicine therapy in familial Mediterranean fever","volume":"86","author":"Wright","year":"1977","journal-title":"Annals of Internal Medicine"},{"issue":"18","key":"10.1002\/14651858.CD010893.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM197410312911803","article-title":"A controlled trial of colchicine in preventing attacks of familial Mediterranean fever","volume":"291","author":"Zemer","year":"1974","journal-title":"New England Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD010893.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/01.CIR.97.21.2183","article-title":"Colchicine treatment for recurrent pericarditis. A decade of experience","volume":"97","author":"Adler","year":"1998","journal-title":"Circulation"},{"issue":"10","key":"10.1002\/14651858.CD010893.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1007\/s00296-010-1474-6","article-title":"Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever","volume":"32","author":"Alpay","year":"2012","journal-title":"Rheumatology International"},{"issue":"8022","key":"10.1002\/14651858.CD010893.pub4-BIB0025|cit25","first-page":"1140","article-title":"Colchicine in familial Mediterranean fever","volume":"1","year":"1977","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub4-BIB0026|cit26","first-page":"4","article-title":"Colchicine for familial Mediterranean fever","volume":"13","year":"1983","journal-title":"FDA Drug Bulletin"},{"issue":"8","key":"10.1002\/14651858.CD010893.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00431-008-0875-y","article-title":"Sulphasalazine treatment in protracted familial Mediterranean fever arthritis","volume":"168","author":"Bakkaloglu","year":"2009","journal-title":"European Journal of Pediatrics"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-146-11-200706050-00023","article-title":"Treatment of familial Mediterranean fever with anakinra","volume":"146","author":"Belkhir","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"4 Suppl 50","key":"10.1002\/14651858.CD010893.pub4-BIB0029|cit29","first-page":"S49","article-title":"Non-response to colchicine in FMF-definition, causes and suggested solutions","volume":"26","author":"Ben-Chetrit","year":"2008","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1002\/art.38777","article-title":"Canakinumab for the treatment of children with colchicine-resistant familial Mediterranean fever: a 6-month open-label, single-arm pilot study","volume":"66","author":"Brik","year":"2014","journal-title":"Arthritis & Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s002280050244","article-title":"Chronic colchicine treatment does not impair glucose tolerance in familial Mediterranean fever patients","volume":"52","author":"Burstein","year":"1997","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00431-007-0547-3","article-title":"The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever","volume":"167","author":"Calligaris","year":"2008","journal-title":"European Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00296-015-3408-9","article-title":"Efficacy and safety of treatments in familial Mediterranean fever: a systematic review","volume":"36","author":"Demirkaya","year":"2016","journal-title":"Rheumatology International"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780190315","article-title":"Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever","volume":"19","author":"Dinarello","year":"1976","journal-title":"Arthritis & Rheumatism"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2362.2007.01868.x","article-title":"Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky","volume":"37","author":"Gattringer","year":"2007","journal-title":"European Journal of Clinical Investigation"},{"issue":"243","key":"10.1002\/14651858.CD010893.pub4-BIB0036|cit36","first-page":"1","article-title":"Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever","volume":"17","author":"G\u00fcl","year":"2015","journal-title":"Arthritis Research & Therapy"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD010893.pub4-BIB0037|cit37","first-page":"S108","article-title":"Long-term efficacy of canakinumab in childhood colchicine resistant familial Mediterranean Fever","volume":"66","author":"Hashkes","year":"2014","journal-title":"Arthritis & Rheumatism"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/14712598.2016.1233963","article-title":"Canakinumab investigated for treating familial Mediterranean fever","volume":"16","author":"Haviv","year":"2016","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"8","key":"10.1002\/14651858.CD010893.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis & Rheumatism"},{"issue":"10","key":"10.1002\/14651858.CD010893.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1093\/rheumatology\/keaa205","article-title":"A systematic literature review of efficacy, effectiveness and safety of biologic therapies for treatment of familial Mediterranean fever","volume":"59","author":"Kuemmerle-Deschner","year":"2020","journal-title":"Rheumatology"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/ard.2007.071498","article-title":"Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra","volume":"66","author":"Kuijk","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/S0049-0172(03)00137-9","article-title":"Colchicine non-responsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization","volume":"33","author":"Lidar","year":"2004","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.rhu.0000255772.25658.7c","article-title":"Familial Mediterranean fever successfully treated with etanercept","volume":"13","author":"Mor","year":"2007","journal-title":"Journal of Clinical Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/ndt\/gfn646","article-title":"Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation","volume":"24","author":"Moser","year":"2009","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejogrb.2008.07.025","article-title":"Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery","volume":"141","author":"Ofir","year":"2008","journal-title":"European Journal of Obstetrics, Gynaecology and Reproductive Biology"},{"issue":"5","key":"10.1002\/14651858.CD010893.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/1744666X.2017.1313116","article-title":"Canakinumab for the treatment of familial Mediterranean fever","volume":"13","author":"Ozdogan","year":"2017","journal-title":"Expert Review of Clinical Immunology"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jbspin.2008.04.001","article-title":"Anakinra: new therapeutic approach in children with familial Mediterranean fever resistant to colchicine","volume":"75","author":"Roldan","year":"2008","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub4-BIB0048|cit48","first-page":"435","article-title":"Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever","volume":"24","author":"Sakallioglu","year":"2006","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"7","key":"10.1002\/14651858.CD010893.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ndt\/15.7.1098","article-title":"Colchicine in the treatment of renal amyloidosis secondary to familial Mediterranean fever","volume":"15","author":"Sarkissian","year":"2000","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"4 Suppl 26","key":"10.1002\/14651858.CD010893.pub4-BIB0050|cit50","first-page":"S43","article-title":"Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient","volume":"20","author":"Seyahi","year":"2002","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"5 Suppl 42","key":"10.1002\/14651858.CD010893.pub4-BIB0051|cit51","first-page":"S99","article-title":"Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents","volume":"24","author":"Seyahi","year":"2006","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD010893.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/ndt\/gfr528","article-title":"Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure","volume":"27","author":"Stankovic Stojanovic","year":"2012","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD010893.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","article-title":"Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review","volume":"72","author":"Ter Haar","year":"2013","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4 Suppl 24","key":"10.1002\/14651858.CD010893.pub4-BIB0054|cit54","first-page":"S37","article-title":"The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: a double-blind, placebo-controlled trial","volume":"22","author":"Tunca","year":"2004","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"7","key":"10.1002\/14651858.CD010893.pub4-BIB0055|cit55","first-page":"1362","article-title":"Interferon-alpha as a treatment modality for colchicine-resistant familial Mediterranean fever","volume":"35","author":"Tweezer-Zaks","year":"2008","journal-title":"Journal of Rheumatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD010893.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/annrheumdis-2017-eular.6885","article-title":"The efficacy of different colchicine doses in treatment of familial Mediterranean fever patients","volume":"76","author":"Uguztemur","year":"2017","journal-title":"Annals of Rheumatic Diseases"},{"issue":"10","key":"10.1002\/14651858.CD010893.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/aje\/kwr460","article-title":"Triggers for attacks in familial Mediterranean fever: application of the case-crossover design","volume":"175","author":"Yenokyan","year":"2012","journal-title":"American Journal of Epidemiology"},{"issue":"16","key":"10.1002\/14651858.CD010893.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","article-title":"Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever","volume":"314","author":"Zemer","year":"1986","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD010893.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/art.1780340806","article-title":"Long-term colchicine treatment in children with familial Mediterranean fever","volume":"34","author":"Zemer","year":"1991","journal-title":"Arthritis & Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/cpt.1302","article-title":"Dosage considerations for canakinumab in children with periodic fever syndromes","volume":"106","author":"Zhuang","year":"2019","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0061|cit61","unstructured":"Tocilizumab for the treatment of familial Mediterranean fever clinicaltrials.gov\/ct2\/show\/NCT03446209"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0062|cit62","unstructured":"Randomized, double-blind, parallel group comparison trial of tocilizumab for colchicine-resistant familial Mediterranean fever upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000032030"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000018328","article-title":"An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance: study protocol for investigator-initiated, multicenter, open-label trial","volume":"99","author":"Koga","year":"2020","journal-title":"Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-018-3105-6","article-title":"Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial","volume":"19","author":"Koga","year":"2018","journal-title":"Trials"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/ndt\/17.11.1921","article-title":"MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study","volume":"17","author":"Balci","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10067-002-0682-1","article-title":"Serum sIL-2r, IL-6, IL-10 and\u00a0TNF-alpha\u00a0level\u00a0in\u00a0familial Mediterranean fever\u00a0patients","volume":"22","author":"Baykal","year":"2003","journal-title":"Clinical Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/kei140","article-title":"Mechanism\u00a0of the\u00a0anti-inflammatory\u00a0effect\u00a0of\u00a0colchicine\u00a0in\u00a0rheumatic diseases: a possible new outlook through microarray analysis","volume":"45","author":"Ben-Chetrit","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1002\/14651858.CD010893.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/RHU.0b013e31823682f5","article-title":"Effects of anti-tumor necrosis factor agents for familial Mediterranean fever patients with chronic arthritis and\/or sacroiliitis who were resistant to colchicine treatment","volume":"17","author":"Bilgen","year":"2011","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0069|cit69","unstructured":"Boutron I Page MJ Higgins JP Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"10","key":"10.1002\/14651858.CD010893.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood.V95.10.3223","article-title":"The\u00a0gene\u00a0for\u00a0familial\u00a0Mediterranean\u00a0fever,\u00a0MEFV, is\u00a0expressed\u00a0in\u00a0early\u00a0leukocyte\u00a0development\u00a0and is\u00a0regulated\u00a0in response\u00a0to\u00a0inflammatory\u00a0mediators","volume":"95","author":"Centola","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1568010053622984","article-title":"Pharmacological and clinical basis of treatment of familial Mediterranean fever (FMF) with colchicine or analogues: an update","volume":"4","author":"Cerquaglia","year":"2005","journal-title":"Current Drug Targets.\u00a0Inflammation\u00a0and\u00a0Allergy"},{"issue":"5","key":"10.1002\/14651858.CD010893.pub4-BIB0072|cit72","first-page":"467","article-title":"Advances\u00a0in the\u00a0understanding\u00a0of\u00a0familial\u00a0Mediterranean\u00a0fever\u00a0and\u00a0possibilities\u00a0for\u00a0targeted\u00a0therapy","volume":"146","author":"Chae","year":"2009","journal-title":"British\u00a0Journal of\u00a0Haematology"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0073|cit73","first-page":"S3","article-title":"The\u00a0inflammatory\u00a0process\u00a0of\u00a0gout\u00a0and its\u00a0treatment","volume":"8 Suppl 1","author":"Cronstein","year":"2006","journal-title":"Arthritis\u00a0Research and\u00a0Therapy"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0074|cit74","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm811","article-title":"Cytokine\u00a0traps:\u00a0multi-component,\u00a0high-affinity\u00a0blockers\u00a0of\u00a0cytokine\u00a0action","volume":"9","author":"Economides","year":"2003","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0077|cit77","unstructured":"Endnote X9 Thomson Reuters 2018"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub4-BIB0078|cit78","first-page":"25","article-title":"A\u00a0candidate\u00a0gene\u00a0for\u00a0familial Mediterranean fever","volume":"17","author":"French FMF Consortium","year":"1997","journal-title":"Nature Genetics"},{"issue":"25","key":"10.1002\/14651858.CD010893.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJM197212212872514","article-title":"Colchicine\u00a0for\u00a0familial Mediterranean fever","volume":"287","author":"Goldfinger","year":"1972","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0080|cit80","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/eji.201746947","article-title":"Function and mechanism of the pyrin inflammasome","volume":"48","author":"Heilig","year":"2018","journal-title":"European Journal of Immunology"},{"issue":"7414","key":"10.1002\/14651858.CD010893.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0083|cit83","unstructured":"Higgins JP Altman DG Sterne JA on behalf of the CSMG and theCBMG Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub4-BIB0084|cit84","first-page":"721","article-title":"Effects\u00a0of\u00a0colchicine\u00a0on\u00a0inflammatory\u00a0cytokines\u00a0and\u00a0selectins\u00a0in\u00a0familial\u00a0Mediterranean\u00a0fever","volume":"16","author":"Kiraz","year":"1998","journal-title":"Clinical\u00a0and Experimental Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jbspin.2010.09.021","article-title":"Current\u00a0data\u00a0on\u00a0familial Mediterranean fever","volume":"78","author":"Kon\u00e9-Paut","year":"2011","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1002\/14651858.CD010893.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/ard.62.5.479","article-title":"Familial Mediterranean fever\u00a0associated\u00a0pyrin\u00a0mutations\u00a0in\u00a0Greece","volume":"62","author":"Konstantopoulos","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub4-BIB0087|cit87","first-page":"50","article-title":"Familial Mediterranean fever\u00a0is no\u00a0longer\u00a0a\u00a0rare disease\u00a0in\u00a0Italy","volume":"11","author":"La Regina","year":"2003","journal-title":"European\u00a0Journal of\u00a0Human Genetics"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0088|cit88","unstructured":"Lefebvre C Glanville J Briscoe S Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub4-BIB0089|cit89","first-page":"1089","article-title":"The\u00a0prodrome: a\u00a0prominent\u00a0yet\u00a0overlooked\u00a0pre-attack\u00a0manifestation\u00a0of\u00a0familial\u00a0Mediterranean\u00a0fever","volume":"33","author":"Lidar","year":"2006","journal-title":"Journal of Rheumatology"},{"issue":"10","key":"10.1002\/14651858.CD010893.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/art.1780401023","article-title":"Criteria for the diagnosis of familial Mediterranean fever","volume":"40","author":"\u00a0Langevitz","year":"1997","journal-title":"Arthritis\u00a0and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/berh.2000.0089","article-title":"Diagnostic and treatment concerns in familial Mediterranean fever","volume":"14","author":"Livneh","year":"2000","journal-title":"Bailli\u00e8re's Best Practice & Research. Clinical Rheumatology"},{"issue":"10","key":"10.1002\/14651858.CD010893.pub4-BIB0092|cit92","first-page":"743","article-title":"Amyloidosis\u00a0of\u00a0familial Mediterranean fever\u00a0(FMF) \u2013 insights to FMF phenotype II","volume":"145","author":"Livneh","year":"2006","journal-title":"Harefuah"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub4-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1182\/blood.V98.3.851","article-title":"The\u00a0familial\u00a0Mediterranean\u00a0fever\u00a0protein,\u00a0pyrin,\u00a0associates\u00a0with\u00a0microtubules\u00a0and\u00a0colocalizes\u00a0with\u00a0actin\u00a0filaments","volume":"98","author":"Mansfield","year":"2001","journal-title":"Blood"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0094|cit94","unstructured":"McKenzie JE Brennan SE Ryan RE Thomson HJ Johnston RV Chapter 9: Summarizing study characteristics and preparing for synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook \u00a0 \u00a0"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/ard.59.11.910","article-title":"A survey of phenotype II in familial Mediterranean fever","volume":"59","author":"Meliko\u011flu","year":"2000","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MD.0b013e318277cf75","article-title":"Familial Mediterranean fever\u00a0in\u00a0Japan","volume":"91","author":"Migita","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijsu.2011.10.001","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"10","author":"Moher","year":"2012","journal-title":"International Journal of Surgery"},{"issue":"8","key":"10.1002\/14651858.CD010893.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s10067-012-2009-1","article-title":"Infliximab therapy for familial Mediterranean fever-related amyloidosis: case series with long term follow-up","volume":"31","author":"\u00d6z\u00e7akar","year":"2012","journal-title":"Clinical Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3899\/jrheum.100718","article-title":"Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine","volume":"38","author":"Ozen","year":"2011","journal-title":"Journal of Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"253","key":"10.1002\/14651858.CD010893.pub4-BIB0102|cit102","first-page":"1","article-title":"Familial Mediterranean fever: recent developments in pathogenesis and new recommendations for management","volume":"8","author":"Ozen","year":"2017","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"10.1002\/14651858.CD010893.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nature Immunology"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0104|cit104","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide\u00a0selectively\u00a0inhibits\u00a0tumor\u00a0necrosis\u00a0factor\u00a0alpha\u00a0production\u00a0by\u00a0stimulated\u00a0human\u00a0monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"Journal of Experimental Medicine"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0106|cit106","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/GIM.0b013e3182060456","article-title":"Familial\u00a0Mediterranean\u00a0fever \u2013 a\u00a0review","volume":"13","author":"Shohat","year":"2011","journal-title":"Genetics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.autrev.2012.07.019","article-title":"Familial Mediterranean fever:\u00a0new\u00a0phenotypes","volume":"12","author":"Soriano","year":"2012","journal-title":"Autoimmunity Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2008.08.006","article-title":"Colchicine\u00a0update:\u00a02008","volume":"38","author":"Terkeltaub","year":"2009","journal-title":"Seminars\u00a0in\u00a0Arthritis\u00a0and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/ar4159","article-title":"Rilonacept\u00a0in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator","volume":"15","author":"Terkeltaub","year":"2013","journal-title":"Arthritis Research and Therapy"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","article-title":"Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever","volume":"90","author":"The International FMF Consortium","year":"1997","journal-title":"Cell"},{"key":"10.1002\/14651858.CD010893.pub4-BIB0112|cit112","unstructured":"World Health Organization 19th Expert Committee: Expert reviews www.who.int\/selection_medicines\/committees\/expert\/19\/reviews\/en\/index.html"},{"issue":"7517","key":"10.1002\/14651858.CD010893.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature13449","article-title":"Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome","volume":"513","author":"Xu","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/rheumatology\/ken509","article-title":"A new set of criteria for the diagnosis of familial Mediterranean fever in childhood","volume":"48","author":"Yal\u00e7inkaya","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub4-BIB0115|cit115","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010893.pub2","article-title":"Interventions for reducing inflammation in familial Mediterranean fever","author":"Wu","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010893.pub4-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010893.pub3","article-title":"Interventions for reducing inflammation in familial Mediterranean fever","author":"Wu","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T18:32:42Z","timestamp":1751308362000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010893.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":116,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010893.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,29]]}}}